| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 29/09/2008 | 23:02 | Edgar (US Regulatory) | Avant Immunotherapeutics Inc - Current report filing (8-K) | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 29/09/2008 | 17:43 | Edgar (US Regulatory) | Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 29/09/2008 | 14:00 | Business Wire | AVANT Immunotherapeutics Announces Name Change to Celldex Therapeutics | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 19/09/2008 | 16:28 | Edgar (US Regulatory) | Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 18/09/2008 | 22:00 | Business Wire | AVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23 | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 13/08/2008 | 22:53 | Edgar (US Regulatory) | Avant Immunotherapeutics Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 08/08/2008 | 22:16 | Business Wire | AVANT CEO to Present at the 28th Annual Canaccord Adams Global Growth Conference | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 06/08/2008 | 14:46 | Business Wire | CORRECTING and REPLACING AVANT Reports Second Quarter and Six Month Financial Results | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 06/08/2008 | 14:00 | Business Wire | AVANT Reports Second Quarter and Six Month Financial Results | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 04/08/2008 | 19:56 | Business Wire | AVANT to Report Second Quarter 2008 Financial Results on August 6, 2008 | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 26/06/2008 | 22:47 | Edgar (US Regulatory) | Avant Immunotherapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 18/06/2008 | 17:13 | Edgar (US Regulatory) | Avant Immunotherapeutics Inc - Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 11/06/2008 | 14:00 | Business Wire | AVANT Announces Vaccine Adjuvant Licenses with 3M | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 04/06/2008 | 16:00 | Business Wire | AVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 04/06/2008 | 13:00 | Business Wire | NIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 03/06/2008 | 14:30 | Marketwired | Market Pulse Breaking News Alert for Tuesday, June 3, 2008: NCEN NACEL Energy Achieves Objectives With 640 MW Wind Power in De | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 02/06/2008 | 20:32 | Marketwired | New Analyst Reports for AVANT IMMUNOTHERAPEUTICS, CANADIAN SOLAR INC, LIBERTY MEDIA HOLDING CORPORATION, and BED BATH AND BEYOND | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 23/05/2008 | 22:04 | Edgar (US Regulatory) | Avant Immunotherapeutics Inc - Amended Current report filing (8-K/A) | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 22/05/2008 | 13:00 | PR Newswire (US) | AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 21/05/2008 | 13:00 | PR Newswire (US) | AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer | NYSE:AVAN | |
| 19/05/2008 | 23:27 | Edgar (US Regulatory) | Avant Immunotherapeutics Inc - Quarterly Report (10-Q) | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 19/05/2008 | 23:33 | Business Wire | AVANT Reports First Quarter 2008 Financial Results | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 17/05/2008 | 00:16 | Business Wire | AVANT Announces Temporary Postponement of Conference Call | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 14/05/2008 | 22:00 | Business Wire | AVANT to Report First Quarter 2008 Financial Results on May 19, 2008 | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 14/05/2008 | 14:00 | Business Wire | Dr. Una Ryan Departs AVANT Immunotherapeutics | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 09/05/2008 | 16:53 | Edgar (US Regulatory) | Avant Immunotherapeutics Inc - Notification that Quarterly Report will be submitted late (NT 10-Q) | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 16/04/2008 | 22:41 | Business Wire | AVANT to Host Conference Call Today, April 16, 2008, at 5:00 PM to Discuss CDX-110 Partnership with Pfizer | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 16/04/2008 | 22:37 | Business Wire | Pfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 15/04/2008 | 22:05 | Business Wire | Significant Tumor-Specific Immune Response Observed in AVANT's Phase 2 Trial Evaluating CDX-110 with Temozolomide for Treatment | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |
| 04/04/2008 | 14:41 | Business Wire | FDA Approves ROTARIX(R) Rotavirus Vaccine | NASDAQ:AVAN | Avant Immunotherapeutics (MM) |